Cargando…
Association of Beta Blocker Use With Bone Mineral Density in the Framingham Osteoporosis Study: A Cross‐Sectional Study
Some, but not all, prior observational studies have shown that beta blocker (BB) use is associated with lower fracture risk and higher bone mineral density (BMD). Rodent studies show the mechanism to involve the reduction in the effects of beta‐adrenergic signaling on bone remodeling. Because previo...
Autores principales: | Lary, Christine W, Hinton, Alexandra C, Nevola, Kathleen T, Shireman, Theresa I, Motyl, Katherine J, Houseknecht, Karen L, Lucas, F. Lee, Hallen, Sarah, Zullo, Andrew R, Berry, Sarah D, Kiel, Douglas P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507481/ https://www.ncbi.nlm.nih.gov/pubmed/32995691 http://dx.doi.org/10.1002/jbm4.10388 |
Ejemplares similares
-
Pharmacogenomic Effects of β-Blocker Use on Femoral Neck Bone Mineral Density
por: Nevola, Kathleen T, et al.
Publicado: (2021) -
Genome-Wide Pleiotropy of Osteoporosis-Related Phenotypes: The Framingham Study
por: Karasik, David, et al.
Publicado: (2010) -
Dairy Food Intake Is Not Associated with Measures of Bone Microarchitecture in Men and Women: The Framingham Osteoporosis Study
por: Millar, Courtney L., et al.
Publicado: (2021) -
Dairy food intake is not associated with spinal trabecular bone score in men and women: the Framingham Osteoporosis Study
por: Millar, Courtney L., et al.
Publicado: (2022) -
Predictors of Imminent Risk of Nonvertebral Fracture in Older, High‐Risk Women: The Framingham Osteoporosis Study
por: Hannan, Marian T, et al.
Publicado: (2019)